search
Back to results

Needle-embedding Therapy Alleviates Depressive Symptoms and Resets the Function of Executive Control System in Subthreshold Depression People

Primary Purpose

Subthreshold Depression

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
needle-embedding therapy
shame needle-embedding therapy
Sponsored by
Guangdong Provincial Hospital of Traditional Chinese Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Subthreshold Depression focused on measuring Subthreshold Depression, Needle-embedding Therapy, Executive Control System

Eligibility Criteria

18 Years - 30 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Applicants self-identifying with a diminished mood who

  • screened positive for subthreshold depressive symptoms (Centre for Epidemiological Studies Depression Scale (CES-D) ≥ 16;
  • were scheduled for a semistructural clinical interview (the Mini International Neuropsychiatric Interview, the MINI) conducted by specialists in psychiatry to diagnose whether they are SD;
  • were not currently receiving or had a plan to receive a psychotherapy for any kind of mental health problem;
  • had had no psychotherapy for any kind of mental health disorder in the past six months.

Exclusion Criteria:

patients had

  • antidepressant use
  • alcohol dependency
  • psychosis
  • recent suicidalrisk
  • significant cognitive impairment
  • recent bereavement
  • terminal illness on clinical grounds

Sites / Locations

  • The Second Affiliated hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

needle-embedding therapy

shame needle-embedding therapy

Arm Description

The participants in this group will be treated with intradermal thumbtack needle.

The participants in this group will be treated with shame intradermal thumbtack needle.

Outcomes

Primary Outcome Measures

Change in depressive symptoms as assessed by Patient Health Questionnaire-9(PHQ-9)
The PHQ-9 questionnaire can directly reflect the subjective feelings of depressed patients and their changes in treatment. As a severity measure, the PHQ-9 score can range from 0 to 27. since each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day). The higher the score, the more severe the depressive symptoms.

Secondary Outcome Measures

Change of attention network test(ANT)
Combined with spatial cue task and flanker task, Attention Network Test can effectively measure different Attention Network effects. ANT can represent three different attention networks (alertness effect, orientation effect and executive control effect).
Change of psychomotor vigilance task (PVT)
The psychomotor vigilance task (PVT) is a sustained-attention, reaction-timed task that measures the speed with which subjects respond to a visual stimulus. Research indicates increased sleep debt or sleep deficit correlates with deteriorated alertness, slower problem-solving, declined psycho-motor skills, and increased rate of false responding.
Change in health-related quality of life as assessed by Short Form Survey (SF-12).
This questionnaire can reflect the patients' health-related quality of life.SF-12 score ranges from 0 [lowest level of health] to 100 [highest level of health].
Change in anxiety symptoms as assessed by Generalized Anxiety Disorder Assessment (GAD-7).
This questionnaire can reflect the anxiety symptoms of patients.GAD-7 score ranges from 0 [no anxiety] to 21 [severe anxiety].

Full Information

First Posted
March 18, 2020
Last Updated
March 21, 2020
Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT04319562
Brief Title
Needle-embedding Therapy Alleviates Depressive Symptoms and Resets the Function of Executive Control System in Subthreshold Depression People
Official Title
Needle-embedding Therapy Alleviates Depressive Symptoms and Resets the Function of Executive Control System in Subthreshold Depression People: a Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
April 1, 2020 (Anticipated)
Primary Completion Date
August 31, 2022 (Anticipated)
Study Completion Date
August 31, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The main objective of this trial is to evaluate the effectiveness of treating subthreshold depression by needle-embedding therapy. On this basis, the investigators will discuss the mechanism of needle-embedding therapy improving executive function control system.
Detailed Description
The needle-embedding therapy is a method of acupuncture, which inserts the intradermal thumbtack needle into skin quickly. The needle will be replaced after 2 or 3 days. This treatment has a great efficacy on subthreshold depression (SD) and it is easy to promote. However, its clinical effect remains to be studied. In this study, the researchers used this method to treat SD by selecting the back shu acupoint and ear acupoint. This research aims to evaluate the effectiveness of treating subthreshold depression by needle-embedding therapy. On this basis, from the perspective of psychology, this project takes the cognitive function of the SD people as the entry point, in order to find the scientific indicators to quantify the SD people clinically from the perspective of the executive function control system. At the same time, magnetic resonance imaging(MRI) was used to compare and analyze the brain executive control system of subthreshold depression group and normal group, and to observe the specificity of brain structure, network and function of subthreshold depression group. Finally, through the comparative analysis of the brain executive control system of the subthreshold depression group with intradermal thumbtack needle therapy and shame intradermal thumbtack needle therapy, the neural mechanism of needle-embedding therapy promoting the function reset of the brain executive control system was speculated based on the evaluation of the efficacy of needle-embedding therapy. 80 patients will be divided into two groups randomly, intradermal thumbtack needle group or shame intradermal thumbtack needle group, and evaluated before and after intervention. The primary study outcomes will be depressive symptoms as measured by the PHQ-9. Secondary outcomes will be the ability of executive control system, health-related quality of life and anxiety symptoms measured as described previously. Tertiary outcomes will be the difference between the results of fMRI of SD people and normal brain database, and the difference between the treatment group and control group, which can observe the specificity of brain structure, network and function in subthreshold depression. The results will be analyzed and presented descriptively, as of statistical comparisons of pre- and post-treatment and the relationship between the groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Subthreshold Depression
Keywords
Subthreshold Depression, Needle-embedding Therapy, Executive Control System

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
needle-embedding therapy
Arm Type
Experimental
Arm Description
The participants in this group will be treated with intradermal thumbtack needle.
Arm Title
shame needle-embedding therapy
Arm Type
Sham Comparator
Arm Description
The participants in this group will be treated with shame intradermal thumbtack needle.
Intervention Type
Procedure
Intervention Name(s)
needle-embedding therapy
Intervention Description
First group is comprised of Xinshu (BL15), Ganshu (BL18), Juque (CV14) bilaterally, and Xin and Gan of auricular point on the left ear. Second group includes Shentang (BL44), Hunmen (BL47), Jiuwei (RN15) bilaterally, and Xin and Gan of auricular point on the right side. After skin cleansing with a 75% alcohol swab, intradermal thumbtack needle will be quickly inserted into the skin and embedded at acupoints mentioned above bilaterally. The needles will remain in the acupoints for 3 days and they will be removed by the therapists at next visit. This also can ensure better implementation of the blind method.Participants are required to receive this treatment twice a week. The specification of the needle used in the back shu point is φ9mm 0.20×1.5mm (Seirin® PYONEX; Seirin Corporation, Shizuoka, Japan), that in the auricular point is φ9mm 0.20×0.6mm (Seirin® PYONEX; Seirin Corporation, Shizuoka, Japan).
Intervention Type
Device
Intervention Name(s)
shame needle-embedding therapy
Intervention Description
The acupoint selection in this group is the same as in the needle-embedding therapy group, except that the shame intradermal needles will be used. After skin cleansing with a 75% alcohol swab, the shame intradermal needles,instead of insert into the skin, it can only stick on the surface of the skin. It also will be removed by the therapists after 3 days. This takes place twice a week. The specification of the shame needle is the same as above.
Primary Outcome Measure Information:
Title
Change in depressive symptoms as assessed by Patient Health Questionnaire-9(PHQ-9)
Description
The PHQ-9 questionnaire can directly reflect the subjective feelings of depressed patients and their changes in treatment. As a severity measure, the PHQ-9 score can range from 0 to 27. since each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day). The higher the score, the more severe the depressive symptoms.
Time Frame
Baseline and 6 weeks, 1-, 3-, 6- and 12-month follow-up
Secondary Outcome Measure Information:
Title
Change of attention network test(ANT)
Description
Combined with spatial cue task and flanker task, Attention Network Test can effectively measure different Attention Network effects. ANT can represent three different attention networks (alertness effect, orientation effect and executive control effect).
Time Frame
Baseline and 6 weeks
Title
Change of psychomotor vigilance task (PVT)
Description
The psychomotor vigilance task (PVT) is a sustained-attention, reaction-timed task that measures the speed with which subjects respond to a visual stimulus. Research indicates increased sleep debt or sleep deficit correlates with deteriorated alertness, slower problem-solving, declined psycho-motor skills, and increased rate of false responding.
Time Frame
Baseline and 6 weeks
Title
Change in health-related quality of life as assessed by Short Form Survey (SF-12).
Description
This questionnaire can reflect the patients' health-related quality of life.SF-12 score ranges from 0 [lowest level of health] to 100 [highest level of health].
Time Frame
Baseline and 6 weeks, 1-, 3-, 6- and 12-month follow-up
Title
Change in anxiety symptoms as assessed by Generalized Anxiety Disorder Assessment (GAD-7).
Description
This questionnaire can reflect the anxiety symptoms of patients.GAD-7 score ranges from 0 [no anxiety] to 21 [severe anxiety].
Time Frame
Baseline and 6 weeks, 1-, 3-, 6- and 12-month follow-up
Other Pre-specified Outcome Measures:
Title
Difference of Functional magnetic resonance imaging scans between two group.
Description
Before the intervention, 40 people were randomly selected to complete the fMRI examination, and the results were compared with the normal brain database. After the intervention, all subjects underwent MR examination, and the treatment group and the control group were compared with each other. The signal of the function, gray matter fiber and white matter fiber of the dorsolateral prefrontal cortex (DLPFC) were extracted from the resting-state fMRI data. These signal will be calculated the functional network of the brain based on graph theory. Therefore, the investigator will compare the difference between two groups.
Time Frame
Baseline and 6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Applicants self-identifying with a diminished mood who screened positive for subthreshold depressive symptoms (Centre for Epidemiological Studies Depression Scale (CES-D) ≥ 16; were scheduled for a semistructural clinical interview (the Mini International Neuropsychiatric Interview, the MINI) conducted by specialists in psychiatry to diagnose whether they are SD; were not currently receiving or had a plan to receive a psychotherapy for any kind of mental health problem; had had no psychotherapy for any kind of mental health disorder in the past six months. Exclusion Criteria: patients had antidepressant use alcohol dependency psychosis recent suicidalrisk significant cognitive impairment recent bereavement terminal illness on clinical grounds
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Wenbin Fu, MD
Phone
+8613808888626
Email
fuwenbin@139.com
First Name & Middle Initial & Last Name or Official Title & Degree
Baile Ning
Phone
13824420916
Email
ningbaile@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Webin Fu, MD
Organizational Affiliation
Guangdong Provincial Hospital of Traditional Chinese Medicine
Official's Role
Study Chair
Facility Information:
Facility Name
The Second Affiliated hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510000
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wenbin Fu
Phone
+8613808888626
Email
fuwenbin@139.com

12. IPD Sharing Statement

Learn more about this trial

Needle-embedding Therapy Alleviates Depressive Symptoms and Resets the Function of Executive Control System in Subthreshold Depression People

We'll reach out to this number within 24 hrs